+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Heart Transplant Market - Global Forecast 2026-2032- Product Image
Heart Transplant Market - Global Forecast 2026-2032- Product Image
Sale

Heart Transplant Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904528
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Heart Transplant Market is projected to reach USD 15.86 Billion in 2026. It is expected to continue growing at a CAGR of 10.41%, reaching USD 28.85 Billion by 2032.

Heart transplantation remains the definitive therapy for selected patients with end-stage heart failure when guideline-directed medical therapy, device therapy, and durable mechanical circulatory support no longer provide adequate survival or quality-of-life benefit. Demand is structurally high as heart failure prevalence rises with population aging, diabetes, hypertension, ischemic heart disease, congenital heart disease survival, and improved cardiomyopathy diagnosis rates.

The heart transplant ecosystem is constrained by donor-organ availability, transplant-center capacity, immunologic matching, perioperative risk, and lifelong immunosuppression needs. Verified registry evidence from OPTN/SRTR and the International Society for Heart and Lung Transplantation shows that annual transplant activity has increased in high-capacity markets, while waitlist pressure, donor conversion, and regional access gaps remain defining clinical and commercial challenges.

Transformative Shifts in the Heart Transplant Landscape

The landscape is shifting from a scarcity-managed model toward a technology-enabled organ utilization model. Donation after circulatory death, normothermic machine perfusion, improved donor assessment, and better logistics are enabling transplant programs to evaluate donor hearts that previously may not have been used, particularly in mature markets with strong procurement networks and specialized cardiac teams.

Policy and payment changes are also reshaping competition. Allocation frameworks increasingly prioritize urgency, broader sharing, measurable outcomes, and equitable access, while hospitals face growing scrutiny on survival, readmissions, infection control, rejection surveillance, and cost efficiency. These shifts favor transplant centers and suppliers that combine clinical excellence with data infrastructure, rapid transport coordination, and post-transplant monitoring capabilities.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative capability across the heart transplant pathway rather than a single product category. AI-enabled analytics can support candidate risk stratification, donor-recipient matching, imaging interpretation, hemodynamic trend analysis, donor-heart suitability assessment, and early detection of rejection or infection signals from electronic health records, laboratory data, wearables, biopsies, and molecular diagnostics outputs.

The strongest near-term value is decision support, not autonomous decision-making. Industry leaders must validate algorithms against registry-grade outcomes, reduce bias in underrepresented populations, preserve clinician oversight, and comply with medical-device, privacy, and cybersecurity regulations. Programs that integrate AI with transplant registry data, multidisciplinary review, and clinical governance are best positioned to improve organ utilization, patient surveillance, and long-term graft survival.

Key Regional Insights

Asia-Pacific is expanding through rising tertiary-care investment, larger heart failure populations, and growing transplant programs in China, India, Japan, South Korea, and Australia, although deceased-donor availability, public awareness, allocation governance, and reimbursement consistency vary widely. North America remains the highest-capacity region, led by the United States and Canada, supported by mature organ procurement networks, advanced mechanical circulatory support, established transplant-center accreditation, and robust outcomes reporting through national registries.

Latin America shows selective growth through established programs in Brazil and Mexico, but access remains uneven due to infrastructure gaps, donor conversion challenges, ICU capacity, and financing constraints. Europe benefits from national transplant authorities, public reimbursement, cross-border collaboration, and organ-sharing frameworks such as Eurotransplant, while the Middle East is investing in specialty cardiac centers, organ donation regulations, and advanced heart failure services. Africa remains an underpenetrated region where heart transplant activity is concentrated in a limited number of centers and constrained by workforce availability, critical-care infrastructure, donor-system maturity, and long-term immunosuppression access.

Key Group Insights

ASEAN markets are characterized by growing cardiovascular disease burden and improving tertiary hospitals, but heart transplant capacity remains concentrated in more advanced health systems with established deceased-donor programs, transplant governance, and post-operative intensive care. The GCC is accelerating investment in cardiac centers, transplant regulations, national donor registries, and advanced heart failure services, supported by health transformation strategies and rising demand for complex cardiovascular care.

The European Union benefits from harmonized regulatory standards, public funding, organ-sharing collaboration, and strong clinical research networks, making it a critical hub for transplant protocols, perfusion technologies, immunosuppression management, and post-transplant surveillance. BRICS countries represent large long-term demand pools, with China, India, and Brazil particularly important because of their expanding cardiovascular disease burden and increasing transplant-system capacity. G7 countries lead in research intensity, reimbursement depth, device adoption, registry transparency, and clinical guideline implementation, while NATO member markets overlap with many high-income systems that prioritize resilient medical supply chains, critical-care readiness, emergency preparedness, and cross-border clinical cooperation.

Key Country Insights

The United States leads global heart transplant activity by annual procedure volume, with OPTN data reporting more than 4,500 heart transplants performed in 2023, supported by a national allocation system, established organ procurement organizations, broad use of mechanical circulatory support, and detailed outcomes reporting. Canada maintains strong outcomes through regional transplant programs, public reimbursement, and coordinated donation systems, while Mexico and Brazil provide important Latin American capacity despite regional variation in access, donor availability, and specialized center distribution.

In Europe, the United Kingdom, Germany, France, Italy, and Spain operate mature transplant systems with strong public-sector coordination, established cardiac surgery expertise, and structured post-transplant follow-up, while Russia has growing specialized capacity but variable public transparency compared with Western European registries. In Asia-Pacific, China is scaling transplant services under evolving donation reforms and greater national oversight, India has high unmet need with expanding public and private programs, Japan emphasizes strict allocation rules and high-quality outcomes within a constrained donor environment, Australia has established national coordination and advanced retrieval logistics, and South Korea combines advanced hospital infrastructure with strong cardiovascular specialty care and growing transplant capability.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize organ utilization, outcomes transparency, and integrated post-transplant care. Investments in ex vivo perfusion, donor-heart assessment, rapid logistics, molecular rejection surveillance, infection management, immunosuppression optimization, medication adherence support, and remote monitoring can directly address the core constraints of donor scarcity and long-term graft preservation.

Commercial strategies should be tailored by market maturity. In established markets, differentiation should focus on evidence generation, AI-enabled workflow integration, value-based partnerships with transplant centers, and interoperability with registry and hospital data systems. In emerging markets, organizations should support workforce training, registry development, procurement-system strengthening, quality standards, and affordable financing models that expand safe access without compromising clinical quality.

Research Methodology

This executive summary is based on secondary research from verified public and institutional sources, including transplant registries, peer-reviewed clinical literature, health ministry publications, organ procurement organizations, international transplant societies, and regulatory agencies. Core reference frameworks include OPTN/SRTR, ISHLT registry reporting, Eurotransplant and national transplant authority data, WHO health-system indicators, and published heart failure epidemiology.

The analysis applies triangulation across procedure activity, clinical outcomes, policy changes, reimbursement structures, technology adoption, organ donation frameworks, and regional capacity indicators. Insights were screened for factual consistency, recency, and relevance to heart transplantation, advanced heart failure management, organ preservation, immunosuppression, diagnostics, digital health, and transplant-center operations.

Conclusion

The heart transplant landscape is advancing through the convergence of clinical innovation, organ-preservation technology, digital decision support, and stronger transplant-system governance. The central challenge remains unchanged: demand for suitable donor hearts exceeds supply, making every improvement in organ identification, preservation, allocation, implantation, and post-transplant management strategically important.

Organizations that align evidence-based technologies with transplant workflow realities will capture the strongest opportunities. The future competitive landscape will reward measurable improvements in donor-heart utilization, equitable access, survival outcomes, cost efficiency, regulatory readiness, and lifelong patient monitoring.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Heart Transplant Market, by Transplant Type
7.1. Introduction
7.2. Heterotopic Transplant
7.3. Orthotopic Transplant
7.3.1. Biatrial Technique
7.3.2. Bicaval Technique
7.4. Heart-Lung Transplant
8. Heart Transplant Market, by Graft Preservation
8.1. Introduction
8.2. Machine Perfusion
8.2.1. Hypothermic Perfusion
8.2.2. Normothermic Perfusion
8.3. Static Cold Storage
9. Heart Transplant Market, by Product
9.1. Introduction
9.2. Donor-Based Transplantation
9.2.1. Donation After Brain Death (DBD)
9.2.2. Donation After Circulatory Death (DCD)
9.3. Mechanical Circulatory Support
9.3.1. Left Ventricular Assist Devices (LVAD)
9.3.2. Right Ventricular Assist Devices (RVAD)
9.3.3. Biventricular Assist Devices (BiVAD)
9.4. Total Artificial Heart
9.5. Organ Preservation & Transport Systems
10. Heart Transplant Market, by Patient Age Group
10.1. Introduction
10.2. Adult
10.3. Geriatric
10.4. Pediatric
11. Heart Transplant Market, by End User
11.1. Introduction
11.2. Hospitals
11.3. Transplant Centers
11.4. Specialty Cardiac Centers
12. Heart Transplant Market, by Indication
12.1. Introduction
12.2. Congenital Heart Disease
12.3. Dilated Cardiomyopathy
12.4. End Stage Heart Failure
12.5. Ischemic Cardiomyopathy
12.6. Valvular Heart Disease
13. Heart Transplant Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Heart Transplant Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Heart Transplant Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Becton, Dickinson and Company
17.3. Berlin Heart GmbH
17.4. BiVACOR, Inc.
17.5. Boston Scientific Corporation
17.6. Braile Biomédica Indústria Comércio E Representações Ltda.
17.7. BrioHealth Solutions, Inc.
17.8. CARMAT SAS
17.9. CH Biomedical, Inc.
17.10. EUROSETS S.R.L.
17.11. FineHeart
17.12. Fresenius Medical Care AG
17.13. Getinge AB
17.14. Hemovent GmbH
17.15. Jarvik Heart, Inc.
17.16. Johnson & Johnson
17.17. LivaNova PLC
17.18. magAssist Co., Ltd.
17.19. Medtronic plc
17.20. MicroPort Scientific Corporation
17.21. ReliantHeart, Inc.
17.22. SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
17.23. Shenzhen Core Medical Technology Co., Ltd.
17.24. Sun Medical Technology Research Corp.
17.25. SynCardia Systems, LLC
17.26. Terumo Corporation
List of Figures
FIGURE 1. GLOBAL HEART TRANSPLANT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HEART TRANSPLANT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HEART TRANSPLANT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HEART TRANSPLANT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HEART TRANSPLANT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL HEART TRANSPLANT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL HEART TRANSPLANT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL HEART TRANSPLANT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL HETEROTOPIC TRANSPLANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ORTHOTOPIC TRANSPLANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BIATRIAL TECHNIQUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL BICAVAL TECHNIQUE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL HEART-LUNG TRANSPLANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MACHINE PERFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MACHINE PERFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL MACHINE PERFUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HYPOTHERMIC PERFUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL NORMOTHERMIC PERFUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL STATIC COLD STORAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DONOR-BASED TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DONATION AFTER BRAIN DEATH (DBD) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL DONATION AFTER CIRCULATORY DEATH (DCD) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BIVENTRICULAR ASSIST DEVICES (BIVAD) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TOTAL ARTIFICIAL HEART MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ORGAN PRESERVATION & TRANSPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TRANSPLANT CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CONGENITAL HEART DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL DILATED CARDIOMYOPATHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL END STAGE HEART FAILURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ISCHEMIC CARDIOMYOPATHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL VALVULAR HEART DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL HEART TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 110. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 111. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 121. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 130. EUROPE HEART TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. EUROPE HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 132. EUROPE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 133. EUROPE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 134. EUROPE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 135. EUROPE HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 136. EUROPE HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 137. EUROPE HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 138. EUROPE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 139. EUROPE HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 140. EUROPE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 141. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 152. AFRICA HEART TRANSPLANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. AFRICA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 154. AFRICA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 155. AFRICA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 156. AFRICA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 157. AFRICA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 158. AFRICA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 159. AFRICA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 160. AFRICA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 161. AFRICA HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. AFRICA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL HEART TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. ASEAN HEART TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. ASEAN HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 166. ASEAN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 167. ASEAN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 168. ASEAN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 169. ASEAN HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 170. ASEAN HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 171. ASEAN HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 172. ASEAN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 173. ASEAN HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. ASEAN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 175. GCC HEART TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 176. GCC HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 177. GCC HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 178. GCC HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 179. GCC HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 180. GCC HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 181. GCC HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 182. GCC HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 183. GCC HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 184. GCC HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. GCC HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 197. BRICS HEART TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 198. BRICS HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 199. BRICS HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 200. BRICS HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 201. BRICS HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 202. BRICS HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 203. BRICS HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 204. BRICS HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 205. BRICS HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 206. BRICS HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. BRICS HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 208. G7 HEART TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. G7 HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 210. G7 HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 211. G7 HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 212. G7 HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 213. G7 HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 214. G7 HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 215. G7 HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 216. G7 HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 217. G7 HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. G7 HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 219. NATO HEART TRANSPLANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 220. NATO HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 221. NATO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 222. NATO HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 223. NATO HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 224. NATO HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 225. NATO HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 226. NATO HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 227. NATO HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 228. NATO HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. NATO HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 230. GLOBAL HEART TRANSPLANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 234. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 235. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 236. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 237. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 238. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 239. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 240. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. UNITED STATES HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 242. CANADA HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. CANADA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 244. CANADA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 245. CANADA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 246. CANADA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 247. CANADA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 248. CANADA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 249. CANADA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 250. CANADA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 251. CANADA HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 252. CANADA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 253. MEXICO HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 254. MEXICO HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 255. MEXICO HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 256. MEXICO HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 257. MEXICO HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 258. MEXICO HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 259. MEXICO HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 260. MEXICO HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 261. MEXICO HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 262. MEXICO HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. MEXICO HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 264. BRAZIL HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. BRAZIL HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 266. BRAZIL HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 267. BRAZIL HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 268. BRAZIL HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 269. BRAZIL HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 270. BRAZIL HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 271. BRAZIL HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 272. BRAZIL HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 273. BRAZIL HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. BRAZIL HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 279. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 281. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 282. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 283. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 284. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. UNITED KINGDOM HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 286. GERMANY HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. GERMANY HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 288. GERMANY HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 289. GERMANY HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 290. GERMANY HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 291. GERMANY HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 292. GERMANY HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 293. GERMANY HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 294. GERMANY HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 295. GERMANY HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. GERMANY HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 297. FRANCE HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. FRANCE HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 299. FRANCE HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 300. FRANCE HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 301. FRANCE HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 302. FRANCE HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 303. FRANCE HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 304. FRANCE HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 305. FRANCE HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 306. FRANCE HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 307. FRANCE HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 308. RUSSIA HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. RUSSIA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 310. RUSSIA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 311. RUSSIA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 312. RUSSIA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 313. RUSSIA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 314. RUSSIA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 315. RUSSIA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 316. RUSSIA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 317. RUSSIA HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 318. RUSSIA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 319. ITALY HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 320. ITALY HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 321. ITALY HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 322. ITALY HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 323. ITALY HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 324. ITALY HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 325. ITALY HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 326. ITALY HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 327. ITALY HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 328. ITALY HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 329. ITALY HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 330. SPAIN HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 331. SPAIN HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 332. SPAIN HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 333. SPAIN HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 334. SPAIN HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 335. SPAIN HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 336. SPAIN HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 337. SPAIN HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 338. SPAIN HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 339. SPAIN HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 340. SPAIN HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 341. CHINA HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 342. CHINA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 343. CHINA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 344. CHINA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 2017-2032 (USD MILLION)
TABLE 345. CHINA HEART TRANSPLANT MARKET SIZE, BY MACHINE PERFUSION, 2017-2032 (USD MILLION)
TABLE 346. CHINA HEART TRANSPLANT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 347. CHINA HEART TRANSPLANT MARKET SIZE, BY DONOR-BASED TRANSPLANTATION, 2017-2032 (USD MILLION)
TABLE 348. CHINA HEART TRANSPLANT MARKET SIZE, BY MECHANICAL CIRCULATORY SUPPORT, 2017-2032 (USD MILLION)
TABLE 349. CHINA HEART TRANSPLANT MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 350. CHINA HEART TRANSPLANT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 351. CHINA HEART TRANSPLANT MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 352. INDIA HEART TRANSPLANT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 353. INDIA HEART TRANSPLANT MARKET SIZE, BY TRANSPLANT TYPE, 2017-2032 (USD MILLION)
TABLE 354. INDIA HEART TRANSPLANT MARKET SIZE, BY ORTHOTOPIC TRANSPLANT, 2017-2032 (USD MILLION)
TABLE 355. INDIA HEART TRANSPLANT MARKET SIZE, BY GRAFT PRESERVATION, 201

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Berlin Heart GmbH
  • BiVACOR, Inc.
  • Boston Scientific Corporation
  • Braile Biomédica Indústria Comércio E Representações Ltda.
  • BrioHealth Solutions, Inc.
  • CARMAT SAS
  • CH Biomedical, Inc.
  • EUROSETS S.R.L.
  • FineHeart
  • Fresenius Medical Care AG
  • Getinge AB
  • Hemovent GmbH
  • Jarvik Heart, Inc.
  • Johnson & Johnson
  • LivaNova PLC
  • magAssist Co., Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • ReliantHeart, Inc.
  • SENKO MEDICAL INSTRUMENT Mfg. CO., LTD.
  • Shenzhen Core Medical Technology Co., Ltd.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 15.86 Billion
Forecasted Market Value ( USD ) by 2032 $ 28.85 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Heart Transplant - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Heart Transplant - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Market - Global Forecast 2026-2032 - Product Image

Organ Transplant Immunosuppressant Drugs Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Heart Transplant Market Report 2026 - Product Image

Heart Transplant Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Organ Transplant Diagnostics Market - Global Forecast 2026-2032 - Product Image

Organ Transplant Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Organ Transplant Immunosuppressant Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 134 Pages
  • Global
From

About the Heart Transplant Market

The Heart Transplant market is a subset of the larger Surgical Procedures market. It involves the surgical replacement of a diseased or damaged heart with a healthy donor heart. The procedure is typically performed on patients with end-stage heart failure, and is considered a last resort when other treatments have failed. The process of transplantation involves a complex series of steps, including donor selection, organ procurement, and post-operative care. The Heart Transplant market is highly regulated, with strict guidelines in place to ensure the safety of both the donor and recipient. The success of the procedure is largely dependent on the skill of the medical team, as well as the availability of suitable donor organs. Some of the companies in the Heart Transplant market include Medtronic, Abbott, Edwards Lifesciences, and St. Jude Medical. These companies provide a range of products and services related to the procedure, including heart-assist devices, heart valves, and other medical devices. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.